2025
Delineating Contemporary Outcomes of Carotid Revascularization in Younger Patients
Carter W, Zwibelman H, Strosberg D, Cardella J, Aboian E, Chaar C, Arhuidese I. Delineating Contemporary Outcomes of Carotid Revascularization in Younger Patients. Journal Of Vascular Surgery 2025, 81: e48-e50. DOI: 10.1016/j.jvs.2025.03.113.Peer-Reviewed Original ResearchThe Incremental Risk of Major Amputation With Reinterventions in Patients With Peripheral Arterial Disease
Carter W, Alameddine D, Said S, Aboian E, Tonnessen B, Cardella J, Guzman R, Chaar C. The Incremental Risk of Major Amputation With Reinterventions in Patients With Peripheral Arterial Disease. Journal Of Vascular Surgery 2025, 81: e186-e187. DOI: 10.1016/j.jvs.2025.03.332.Peer-Reviewed Original ResearchValidation of the WIfI Classification in the Vascular Quality Initiative database
Alameddine D, Satam K, Slade M, Cardella J, Aboian E, Guzman R, Mills J, Chaar C. Validation of the WIfI Classification in the Vascular Quality Initiative database. Journal Of Vascular Surgery 2025 PMID: 40056961, DOI: 10.1016/j.jvs.2025.03.001.Peer-Reviewed Original ResearchChronic limb-threatening ischemiaWIfI stageWIfI scoreWIfI classificationLower extremity revascularizationPeripheral vascular interventionsMajor amputationAssociated with major amputationWIfI clinical stagePredicting major amputationPeripheral vascular interventional proceduresAssociated with increased riskVascular Quality InitiativeRegression analysisAmputation groupAmputation resultsCox regression analysisLimb-threatening ischemiaCharacteristics of patientsAfrican AmericansQuality InitiativeAmputationRisk factorsExtremity revascularizationFoot Infection classificationAntithrombotic Therapy In Patients With Atrial Fibrillation Undergoing Peripheral Vascular Interventions
Said S, Alameddine D, Aboian E, Strosberg D, Tonnessen B, Cardella J, Guzman R, Chaar C. Antithrombotic Therapy In Patients With Atrial Fibrillation Undergoing Peripheral Vascular Interventions. Annals Of Vascular Surgery 2025, 112: 436-437. DOI: 10.1016/j.avsg.2024.11.070.Peer-Reviewed Original Research
2024
Clinician perspectives regarding CYP2C19 genotype testing in patients with critical limb ischemia: A Delphi approach
Regan C, Scierka L, Dardik A, Tonnessen B, Chaar C, Ionescu C, Aboian E, Cardella J, Nassiri N, Guzman R, Attaran R, Nagpal S, Shah S, Smolderen K, Mena-Hurtado C. Clinician perspectives regarding CYP2C19 genotype testing in patients with critical limb ischemia: A Delphi approach. Vascular 2024, 33: 466-471. PMID: 38669051, DOI: 10.1177/17085381241246318.Peer-Reviewed Original ResearchDual antiplatelet therapyPeripheral arterial diseaseCYP2C19 testingCYP2C19 mutationsHeterogeneity of treatment effectsPeripheral vascular interventionsConsensus statementKnowledge questionsAntiplatelet therapyGenetic testingVascular surgeryAcademic health systemBarriers to implementationInterquartile rangeCYP2C19 genotype testingVascular diseaseInterventional cardiologyModified Delphi methodPatient's metabolic statusManagement of patientsCritical limb ischemiaPerceived barriersPeripheral vascular diseaseArterial vascular diseaseClinician perspectives
2023
The Utilization of Protamine during Peripheral Vascular Interventions in the VQI
Ali S, Shebl F, Aboian E, Strosberg D, Fischer U, Cardella J, Guzman R, Ochoa Chaar C. The Utilization of Protamine during Peripheral Vascular Interventions in the VQI. Annals Of Vascular Surgery 2023, 101: 72-79. PMID: 38110083, DOI: 10.1016/j.avsg.2023.10.019.Peer-Reviewed Original ResearchPeripheral vascular interventionsAdjusted rate ratiosProtamine useCardiac complicationsPropensity matchingVascular interventionsChronic obstructive pulmonary diseasePropensity scoreCharacteristics of patientsPeripheral arterial diseaseCongestive heart failureObstructive pulmonary diseaseMultivariable Poisson regressionUse of protamineSignificant differencesMedical comorbiditiesP2Y12 inhibitorsPerioperative bleedingPerioperative medicationsPerioperative outcomesDistal embolizationPatient comorbiditiesCarotid surgeryHeart failurePulmonary disease
2022
The Use of Negative Pressure Wound Therapy After Arterial Vascular Reconstructions
Kostiuk V, Setia O, Cardella J, Strosberg D, Tonnessen B, Guzman R, Aboian E. The Use of Negative Pressure Wound Therapy After Arterial Vascular Reconstructions. Journal Of Vascular Surgery 2022, 76: e26-e27. DOI: 10.1016/j.jvs.2022.06.053.Peer-Reviewed Original ResearchThe Use of Protamine During Peripheral Vascular Interventions in the Vascular Quality Initiative
Ali S, Shebl F, Aboian E, Strosberg D, Fischer U, Cardella J, Guzman R, Chaar C. The Use of Protamine During Peripheral Vascular Interventions in the Vascular Quality Initiative. Journal Of Vascular Surgery 2022, 75: e285. DOI: 10.1016/j.jvs.2022.03.645.Peer-Reviewed Original ResearchIncidence and Characteristics of Deep Venous Reflux in Patients Treated for Superficial Venous Disease with Ablation
Satam K, Aurshina A, Zhuo H, Zhang Y, Cardella J, Aboian E, Tonnessen B, Guzman R, Chaar C. Incidence and Characteristics of Deep Venous Reflux in Patients Treated for Superficial Venous Disease with Ablation. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2022, 10: 568-570. DOI: 10.1016/j.jvsv.2021.12.055.Peer-Reviewed Original Research
2021
Eligibility of Patients With Chronic Limb-Threatening Ischemia for Deep Venous Arterialization Before Amputation
Satam K, Aboian E, Huttler J, Zhuo H, Zhang Y, Tonnessen B, Cardella J, Guzman R, Chaar C. Eligibility of Patients With Chronic Limb-Threatening Ischemia for Deep Venous Arterialization Before Amputation. Journal Of Vascular Surgery 2021, 74: e175. DOI: 10.1016/j.jvs.2021.06.262.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply